A study led by the Margarita Salas Center for Biological Research (CSIC) reveals the mechanism by which FtsZ filaments assemble and disassemble to allow cell division of Staphylococcus aureus, one of the deadliest antibiotic-resistant bacteria. Part of the experiment was done at the XALOC beamline of the ALBA Synchrotron.
A study published in ACS Applied Materials & Interfaces studies the asymmetry of the magnetic proximity effect in both heavy metals-ferromagnetic-heavy metal trilayers and, for the first time, in multilayered systems. The study, that counted with the collaboration of the BOREAS beamline at ALBA, will provide useful guidelines to the design and production of advanced spintronic devices based on multilayered systems, with applications in information and communication technologies.
A recent work of the Universitat Autònoma de Barcelona (UAB) in collaboration with the ALBA Synchrotron, has studied the side effects of typical tooth whitening treatments, based on oxidation, compared to a new treatment developed by the authors through reduction. Results showed the whitening effect of the novel treatment to be highly improved in terms of application time needed, efficiency and safety, which makes it a promising candidate to develop novel whitening treatments. Experiments at the MIRAS beamline of ALBA helped to determine the chemical mineral modifications in the dental enamel.
The ALBA Synchrotron and the Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) are developing a new system to manufacture low-cost and ultrafast superconducting tapes (key in the field of green energy since they allow the transport and generation of energy in a much more efficient way). The NCD-SWEET beamline has recently hosted the first experiments. This project has received funding under the Recovery, Transformation and Resilience Plan and the NextGenerationEU funds.
Led by researcher Tanja Ducic, beamline scientist from the MIRAS beamline at the ALBA Synchrotron, the live-cells study has revealed variations in the organic compounds of different glioblastoma cells and it confirms the efficacy of the riluzole drug against this type of cancer.
